 LifeSci Acquisition Corp. LSACU, a blank check company targeting the biopharma, medical technology, digital health and healthcare services sectors, announced today that it closed its initial public offering of 6,000,000 units, upsized from 5,000,000 units, at a price of 10.00 per unit. The underwriters have been granted a 45-day option to purchase up to an additional 900,000 units offered by LifeSci Acquisition to cover over-allotments, if any. The units are listed on the NASDAQ Capital Market NASDAQ and began trading under the symbol LSACU on March 6, 2020. 